Cardlytics Q2 2023 Earnings Report
Key Takeaways
Cardlytics reported a 2% year-over-year increase in revenue, reaching $76.7 million. The company's net loss attributable to common stockholders significantly improved to $(23.5) million, compared to $(126.3) million in the second quarter of 2022. Key metrics such as MAUs also saw growth, while ARPU remained consistent year-over-year.
Revenue increased by 2% year-over-year to $76.7 million.
Billings increased by 2% year-over-year to $109.4 million.
Net loss attributable to common stockholders improved to $(23.5) million, or $(0.67) per diluted share.
Cardlytics MAUs increased by 5% year-over-year to 188.1 million.
Cardlytics
Cardlytics
Forward Guidance
Cardlytics anticipates billings to be between $111.0 million and $123.0 million and revenue to be between $75.0 million and $84.0 million for Q3 2023.